![Alan R. Meyer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Alan R. Meyer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OcuSub, Inc.
![]() OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
Gründer | 01.01.2002 | - | |
Vorstandsvorsitzender | 01.01.2002 | 01.01.2018 |
Karriereverlauf von Alan R. Meyer
Ehemalige bekannte Positionen von Alan R. Meyer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
OCUPHIRE PHARMA, INC. | Direktor/Vorstandsmitglied | - | 07.06.2021 |
Gründer | 01.02.2018 | 07.06.2021 | |
AKSYS LTD. | Direktor/Vorstandsmitglied | - | 23.06.2006 |
PathoGenesis Corp
![]() PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Direktor/Vorstandsmitglied | 01.01.1992 | 01.01.2000 |
Finanzdirektor/CFO | 01.01.1992 | 01.01.2000 |
Ausbildung von Alan R. Meyer
University of Illinois | Undergraduate Degree |
Kellogg School of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Director/Board Member | 4 |
Founder | 2 |
Chief Executive Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AKSYS LTD. | Finance |
OCUPHIRE PHARMA, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
OcuSub, Inc.
![]() OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Health Technology |
PathoGenesis Corp
![]() PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
- Börse
- Insiders
- Alan R. Meyer
- Erfahrung